Brind.
  1. Evotec, Bristol Myers Squibb, and Sandoz announced the evolution of their strategic partnership and financial results from Hamburg.
  2. Sandoz and Evotec announced a strategic partnership and potential sale of the Just - Evotec Biologics EU site in Toulouse.

Sandoz is facing issues regarding the absence of licensing payments related to the strategic partnership with Evotec.

1 report, 1 independent Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sandoz is facing issues regarding the absence of licensing payments related to the strategic partnership with Evotec.

Who's involved

What this event is mainly about
SandozEvotec

Keep exploring

Part of

Sandoz and Evotec announced a strategic partnership and potential sale of the Just - Evotec Biologics EU site in Toulouse. All 2 developments

Within Evotec, Bristol Myers Squibb, and Sandoz announced the evolution of their strategic partnership and financial results from Hamburg.

The entities involved

Coverage

Newest first; wire copies grouped